Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Listen now
Description
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200211 
More Episodes
Dr. Irfan Sheikh finishes out his five-part series about idiopathic generalized epilepsy with a discussion of epilepsy with generalized tonic-clonic seizures alone. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.  
Published 05/06/24
Published 05/06/24
Dr. Halley Alexander, Dr. Jacqueline French, and Dr. Nora Jandhyala discuss investigating ED recognition of motor vs. non-motor seizures and its effect on the management and treatment of focal epilepsy in adolescents. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209389 
Published 05/03/24